Jordi Casabona

ORCID: 0000-0003-4816-5536
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV/AIDS Research and Interventions
  • HIV, Drug Use, Sexual Risk
  • Sex work and related issues
  • HIV Research and Treatment
  • Adolescent Sexual and Reproductive Health
  • Hepatitis C virus research
  • Syphilis Diagnosis and Treatment
  • Reproductive tract infections research
  • HIV-related health complications and treatments
  • Hepatitis B Virus Studies
  • Pneumocystis jirovecii pneumonia detection and treatment
  • HIV/AIDS drug development and treatment
  • COVID-19 Clinical Research Studies
  • Viral-associated cancers and disorders
  • HIV/AIDS oral health manifestations
  • Sexuality, Behavior, and Technology
  • Opioid Use Disorder Treatment
  • COVID-19 and Mental Health
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS Impact and Responses
  • Vaccine Coverage and Hesitancy
  • Long-Term Effects of COVID-19
  • Migration, Health and Trauma
  • Poxvirus research and outbreaks
  • COVID-19 Impact on Reproduction

Government of Catalonia
2016-2025

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
2016-2025

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
2016-2025

Instituto de Salud Carlos III
2011-2025

Universitat Autònoma de Barcelona
2016-2025

Centre for Omic Sciences
1998-2025

i2CAT
2023-2025

Departament de Salut
2014-2025

Comunidad de Madrid
1994-2025

Ministry of Health
2023-2024

Few studies have monitored late presentation (LP) of HIV infection over the European continent, including Eastern Europe. Study objectives were to explore impact LP on AIDS and mortality. was defined in Collaboration Observational Epidemiological Research Europe (COHERE) as diagnosis with a CD4 count <350/mm(3) or an within 6 months among persons presenting for care between 1 January 2000 30 June 2011. Logistic regression used identify factors associated Poisson AIDS/death. 84,524...

10.1371/journal.pmed.1001510 article EN cc-by PLoS Medicine 2013-09-03

No effective treatments for coronavirus disease 2019 (COVID-19) exist. We aimed to determine whether early treatment with hydroxychloroquine (HCQ) would be efficacious outpatients COVID-19.Multicenter open-label, randomized, controlled trial conducted in Catalonia, Spain, between 17 March and 26 May 2020. Patients recently diagnosed <5-day of symptom onset were assigned receive HCQ (800 mg on day 1 followed by 400 once daily 6 days) or usual care. Outcomes reduction viral load nasopharyngeal...

10.1093/cid/ciaa1009 article EN other-oa Clinical Infectious Diseases 2020-07-13

BackgroundCurrent strategies for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are limited to nonpharmacologic interventions. Hydroxychloroquine has been proposed as a postexposure therapy prevent disease 2019 (Covid-19), but definitive evidence is lacking.MethodsWe conducted an open-label, cluster-randomized trial involving asymptomatic contacts of patients with polymerase-chain-reaction (PCR)–confirmed Covid-19 in Catalonia, Spain. We randomly assigned...

10.1056/nejmoa2021801 article EN New England Journal of Medicine 2020-11-24

Most clinical guidelines recommend that AIDS-free, HIV-infected persons with CD4 cell counts below 0.350 × 10(9) cells/L initiate combined antiretroviral therapy (cART), but the optimal count at which cART should be initiated remains a matter of debate.To identify initiated.Prospective observational data from HIV-CAUSAL Collaboration and dynamic marginal structural models were used to compare initiation strategies for thresholds between 0.200 0.500 cells/L.HIV clinics in Europe Veterans...

10.7326/0003-4819-154-8-201104190-00001 article EN Annals of Internal Medicine 2011-04-19

To describe the CD4 cell count at start of combination antiretroviral therapy (cART) in low-income (LIC), lower middle-income (LMIC), upper (UMIC), and high-income (HIC) countries.Patients aged 16 years or older starting cART a clinic participating multicohort collaboration spanning 6 continents (International epidemiological Databases to Evaluate AIDS ART Cohort Collaboration) were eligible. Multilevel linear regression models adjusted for age, gender, calendar year; missing counts...

10.1097/qai.0b013e3182a39979 article EN JAIDS Journal of Acquired Immune Deficiency Syndromes 2013-07-24
Amanda Mocroft Hansjakob Furrer José M. Miró Peter Reiss Cristina Mussini and 95 more Ole Kirk Sophie Abgrall S. Ayayi Barbara Bartmeyer Dominique L. Braun Antonella Castagna Antonella d’Arminio Monforte Brian Gazzard Félix Gutiérrez Isabel Hurtado Klaus Jansen Laurence Meyer Pepa Muñoz Niels Obel Pere Soler‐Palacín Antonios Papadopoulos F. Raffi J. T. Ramos Jürgen K. Rockstroh Dominique Salmon Carlo Torti J. Warszawski Christoph Stephan Robert Zangerle Céline Fabre-Colin Jesper Kjær Geneviève Chêne Jesper Grarup Jens Lundgren Amanda Mocroft Hansjakob Furrer José M. Miró Peter Reiß Cristina Mussini Ole Kirk Sophie Abgrall S. Ayayi Barbara Bartmeyer Dominique L. Braun Antonella Castagna Antonella d’Arminio Monforte Brian Gazzard Félix Gutiérrez Isabel Hurtado Klaus Jansen Laurence Meyer Pepa Muñoz Niels Obel Pere Soler‐Palacín Antonios Papadopoulos François Raffi José Tomás Ramos Jürgen K. Rockstroh Dominique Salmon‐Céron Carlo Torti Josianne Warszawski Christoph Stephan Robert Zangerle Céline Fabre-Colin Jesper Kjær Geneviève Chêne Jesper Grarup Jens Lundgren Jens Lundgren Jose Miiro Pere Soler‐Palacín Carolo Torti Josiane Warszawski Jürgen K. Rockstroh José Manuel Ramos José M. Miró Pepa Muñoz Ali Judd Josiane Warszawski David Haerry Ian Weller Jordi Casabona Dominique Costagliola Antonella d’Arminio Monforte Manuel Battegay Maria Prins Frank de Wolf Céline Colin Christine Schwimmer Guillaume Touzeau Maria Campbell Julia Bohlius Vincent Bouteloup Heiner C. Bucher Alessandro Cozzi-Lepri François Dabis Maria Dorrucci Matthias Egger Frederik Neess Engsig Olivier Lambotte

Background. Few studies consider the incidence of individual AIDS-defining illnesses (ADIs) at higher CD4 counts, relevant on a population level for monitoring and resource allocation.

10.1093/cid/cit423 article EN Clinical Infectious Diseases 2013-08-06
Antoni Soriano‐Arandes Anna Gatell Pepe Serrano Marchuet Mireia Biosca Ferran Campillo i López and 95 more Ramon Capdevila Anna Fàbrega Zulema Lobato N. López Segura Ana Ma Moreno Miriam Poblet Maria Teresa Riera-Bosch Neus Rius Montserrat Ruíz Almudena Sánchez Cinta Valldepérez Mònica Vilà Valentí Pineda Uxue Lazcano Yesika Díaz Juliana Reyes‐Urueña Pere Soler‐Palacín Marc García-Lorenzo Lorena Braviz Àngels Naranjo Olga Salvadó Silvia Burgaya Lidia Aulet Javier Cantero Gloria Ruiz Marina Fenoy A. Martínez Iris González Anton Foguet Imma Bayona Guillermo García Laia Solé Coromina Clara Calbet Mireia Carulla Neus Piquè Pilar Llobet Berta Pujol Alvaro Díaz‐Conradi Maria Esteller Blanca Rosich Arantxa Gómez Anna Ma Ristol Borja Guarch Francesc Ripoll Maria Chiné Carlos Losana Romina Conti Isabel Zambudio Mercè Escuer J.M. Ramírez Torres Tomàs Maria Pérez-Porcuna Emiliano Mora Roger García-Puig Silvia Salvador do Prado Daniel Gros Mercè Giribet Pili Villalobos Dolors Canadell Xavier Bruna Elisenda Martínez Anna Bordas Alexis Sentís Jordi Aceitón Jordi Casabona Carlos Herrero Isabel Casas Nathalia Joaqui Vanessa Laveglia Grisel Vilagrasa Maria José González Laura Minguell Núria Visa-Reñé Fernando Paredes-Carmona Anna Vidal-Moreso Rosario Díez Ana Sofia Moreira Evelyn Berbel Stephan Schneider Maria Milà Ana Miranda Maldonado Imma Caubet Magda Campins Juliana Esperalba Andrés Antón Jordi Gómez i Prat Raisa Morales José Pedro Fernandes dos Santos Pilar Gussinyé Teresa Fenollosa C Moreno Joan Azemar Xavier Durán Gemma Terrer Evaristo Galdeano Raquel Plasencia

Abstract Background The role of children in household transmission severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains unclear. We describe the epidemiological and clinical characteristics with disease 2019 (COVID-19) Catalonia, Spain, investigate dynamics. Methods A prospective, observational, multicenter study was performed during summer school periods (1 July 2020–31 October 2020) to analyze features viral dynamics COVID-19 patients aged &amp;lt;16 years. pediatric index...

10.1093/cid/ciab228 article EN other-oa Clinical Infectious Diseases 2021-03-09

Abstract Background Before the COVID-19 pandemic, Sexually transmitted infections (STIs) were increasing in Europe, and Spain Catalonia not an exception. has been one of regions with highest number confirmed cases Spain. The objective this study was to estimate magnitude decline, due STI during lockdown de-escalation phases. Methods Interrupted time series analysis performed decline reported - chlamydia, gonorrhoea, syphilis, lymphogranuloma venereum- since historical data, from March 13th...

10.1186/s12889-021-11630-x article EN cc-by BMC Public Health 2021-09-07

Most countries have enacted some restrictions to reduce social contacts slow down disease transmission during the COVID-19 pandemic. For nearly two years, individuals likely also adopted new behaviours avoid pathogen exposure based on personal circumstances. We aimed understand way in which different factors affect - a critical step improving future pandemic responses.The analysis was repeated cross-sectional contact survey data collected standardized international study from 21 European...

10.1186/s12879-023-08214-y article EN cc-by BMC Infectious Diseases 2023-04-26

We conducted a multicentric national study (SEIMC-CEME-22), to describe the clinical and epidemiological profile of mpox outbreak in Spain, including management disease.

10.1093/ofid/ofae105 article EN cc-by-nc-nd Open Forum Infectious Diseases 2024-02-22

The practice of using drugs to modulate experiences is a well-documented phenomenon worldwide, particularly among men who have sex with (MSM). This study aims describe patterns drug combinations used by Brazilian MSM, embracing detailed examination the context, which may inspire research elsewhere while enriching global panorama on MSM use. By focusing sheds light specific use combinations, help in development effective, culturally sensitive public health strategies. investigation was...

10.47626/1516-4446-2024-3874 article EN cc-by-nc Brazilian Journal of Psychiatry 2025-01-01

Background There is a co-occurrence of adolescents’ substance use and sexual practices, with an important impact on their health behaviours; however, limited research conducted adolescents. The aim this study was to estimate the prevalence (alcohol and/or other substances) in contexts identify its associated factors among adolescents, comparing boys girls. Methods Cross-sectional data from 6352 adolescents aged 14­­­–18 years DESKcohort project. Prevalence alcohol (OSUSC) stratified by sex...

10.1071/sh24153 article EN Sexual Health 2025-02-06

Abstract Background Health inequality in Latin America is particularly severe for individuals living with HIV (PLHIV) and key populations, such as men who have sex men, transgender women, people use drugs, workers. Despite regional programs aimed at reducing health inequalities, the Sustainable Development Goals Agenda Americas 2018–2030, COVID-19 crisis has exposed significant shortcomings national healthcare systems PLHIV populations. The multi-country, community-based research program,...

10.1186/s12889-025-22017-7 article EN cc-by BMC Public Health 2025-03-12

The advent of effective combination antiretroviral therapy (ART) in 1996 resulted fewer patients experiencing clinical events, so that some prognostic analyses individual cohort studies human immunodeficiency virus-infected individuals had low statistical power. Because this, the Antiretroviral Therapy Cohort Collaboration (ART-CC) HIV Europe and North America was established 2000, with aim studying prognosis for events acquired immune deficiency syndrome (AIDS) mortality adult treated HIV-1...

10.1093/ije/dyt010 article EN International Journal of Epidemiology 2013-04-18
Ali Judd Robert Zangerle Giota Touloumi Josiane Warszawski Laurence Meyer and 95 more François Dabis Murielle Mary Krause Jade Ghosn Catherine Leport Linda Wittkop Peter Reiss Ferdinand Wit M. Prins Heiner Bucher Diana M. Gibb Gerd Fätkenheuer Del Amo Julia Niels Obel Claire Thorne Amanda Mocroft Ole Kirk Christoph Stephan Santiago Pérez‐Hoyos Osamah Hamouda Barbara Bartmeyer Nikoloz Chkhartishvili Antoni Noguera‐Julián Andrea Antinori Antonella d’Arminio Monforte Norbert H. Brockmeyer Luis Prieto Pablo Rojo Conejo Antoni Soriano‐Arandes Manuel Battegay Roger D. Kouyos Cristina Mussini Pat Tookey Jordi Casabona Jose M Miró Antonella Castagna Deborah Konopnick Tessa Goetghebuer Anders Sönnerborg Eugenia Quirós-Roldán Caroline Sabin Ramón Teira Myriam Garrido David Haerry Christoph Stephan Jose M Miró Dominique Costagliola Antonella d’Arminio Monforte Antonella Castagna Julia del Amo Amanda Mocroft Dorthe Raben Geneviève Chêne Ali Judd Conejo Pablo Rojo Diana Barger Christine Schwimmer Monique Termote Linda Wittkop Maria Campbell Casper Møller Frederiksen Nina Friis‐Møller Jesper Kjær Dorthe Raben Rikke Salbøl Brandt Juan Berenguer Julia Bohlius Vincent Bouteloup Heiner Bucher Alessandro Cozzi‐Lepri François Dabis Antonella d’Arminio Monforte Mary-Anne Davies Julia del Amo Maria Dorrucci David Dunn Matthias Egger Hansjakob Furrer Sophie Grabar Marguerite Guiguet Ali Judd Ole Kirk Olivier Lambotte Valériane Leroy Sara Lodi Sophie Matheron Laurence Meyer Jose M Miró Amanda Mocroft Susana Monge Fumiyo Nakagawa Roger Paredes Andrew W. Phillips Massimo Puoti Eliane Rohner Michael Schomaker

We compared Kaposi sarcoma (KS) risk in adults who started antiretroviral therapy (ART) across the Asia-Pacific, South Africa, Europe, Latin, and North America.

10.1093/cid/cix480 article EN Clinical Infectious Diseases 2017-05-19

The aim of this study was to assess differences in the prevalence HIV and HCV infection associated risk factors between new (injecting for ≤5 years) long-term injectors estimate HIV/HCV incidence among injectors.Cross-sectional people who inject drugs (PWID) attended harm reduction centers Catalonia 2010-11. Anonymous questionnaires oral fluid samples were collected. Poisson regression models applied determine association factors.Of 761 participants, 21.4% injectors. New younger than (mean...

10.3109/10826084.2015.1092991 article EN Substance Use & Misuse 2016-01-28

Abstract We aimed to identify risk factors for Kaposi's sarcoma (KS) among HIV‐positive patients and behaviors associated with human Herpesvirus 8 (HHV‐8) infection, as well assess KS incidence mortality rates longitudinally. To fulfill the first objective, a European case‐control study was designed in early 1990s (each case matched 2 controls another AIDS indicative disease). After discovery of HHV‐8, serology testing enabled us development HHV‐8 HIV‐1 coinfected men who have sex (MSM),...

10.1002/ijc.22281 article EN International Journal of Cancer 2006-12-07

To estimate the prevalence of HIV testing among patients diagnosed with an indicator condition (IC) for HIV, seen in primary care (PC) Catalonia, and to infection those patients.Cross-sectional population-based study aged between 16 65 IC within PC Catalonia.Data used this were extracted from a large public health database Spain, Information System Development Research Primary Care (SIDIAP). All participants registered SIDIAP 1 January 2010 31 August 2012 diagnosis screened identify test...

10.1136/sextrans-2015-052328 article EN Sexually Transmitted Infections 2016-02-17

ABSTRACT Background Current strategies for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are limited to non-pharmacological interventions. Hydroxychloroquine (HCQ) has been proposed as a postexposure therapy prevent Coronavirus disease 2019 (Covid-19) but definitive evidence is lacking. Methods We conducted an open-label, cluster-randomized trial including asymptomatic contacts exposed PCR-positive Covid-19 case in Catalonia, Spain. Clusters were...

10.1101/2020.07.20.20157651 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-07-26
Coming Soon ...